Aprea Therapeutics: HC Wainwright Downgrades to Buy, PT to $1.2 from $4

martes, 31 de marzo de 2026, 7:32 am ET1 min de lectura
APRE--

Aprea Therapeutics: HC Wainwright Downgrades to Buy, PT to $1.2 from $4

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios